Patents by Inventor Miwa KONISHI

Miwa KONISHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11525132
    Abstract: Ligase mutants of the following (1), (2), or (3): (1) a ligase mutant comprising an amino acid sequence showing 95% or more identity to the amino acid sequence of SEQ ID NO: 1, and having a nucleic acid-linking activity; (2) a ligase mutant comprising an amino acid sequence showing 90% or more identity to the amino acid sequence of SEQ ID NO: 2, and having a nucleic acid-linking activity; or (3) a ligase mutant comprising an amino acid sequence showing 97% or more identity to the amino acid sequence of SEQ ID NO: 3, and having a nucleic acid-linking activity, have excellent properties.
    Type: Grant
    Filed: March 23, 2021
    Date of Patent: December 13, 2022
    Assignee: AJINOMOTO CO., INC.
    Inventors: Miwa Konishi, Shohei Kajimoto, Yusuke Hagiwara, Yasuhiro Mihara, Shogo Nakano, Tomoharu Motoyama, Sohei Ito
  • Publication number: 20220041645
    Abstract: Formation of a modified oligonucleotide by treating four or more oligonucleotide raw material fragments in total in the presence of an oligonucleotide ligase; the four or more oligonucleotide raw material fragments in total corresponding to oligonucleotide raw material fragments that are obtained by dividing the modified oligonucleotide at a fragment linking site that satisfies following conditions (i) to (v): (i) one or more fragment linking sites are present in the complementary portion in each strand side, and two or more fragment linking sites in total are present in the modified oligonucleotide; (ii) when the modified oligonucleotide is divided at the fragment linking site, a sticky end is formed in the complementary portion, in which the sticky end has 1 to 10 nucleotide length; (iii) at least one oligonucleotide raw material fragment has a modified nucleotide; (iv) four oligonucleotide raw material fragments out of the four or more oligonucleotide raw material fragments in total include the complementa
    Type: Application
    Filed: August 16, 2021
    Publication date: February 10, 2022
    Applicant: Ajinomoto Co., Inc.
    Inventors: Daisuke TAKAHASHI, Yusuke HAGIWARA, Shohei KAJIMOTO, Miwa KONISHI
  • Publication number: 20210301280
    Abstract: Ligase mutants of the following (1), (2), or (3): (1) a ligase mutant comprising an amino acid sequence showing 95% or more identity to the amino acid sequence of SEQ ID NO: 1, and having a nucleic acid-linking activity; (2) a ligase mutant comprising an amino acid sequence showing 90% or more identity to the amino acid sequence of SEQ ID NO: 2, and having a nucleic acid-linking activity; or (3) a ligase mutant comprising an amino acid sequence showing 97% or more identity to the amino acid sequence of SEQ ID NO: 3, and having a nucleic acid-linking activity, have excellent properties.
    Type: Application
    Filed: March 23, 2021
    Publication date: September 30, 2021
    Applicant: AJINOMOTO CO., INC.
    Inventors: Miwa KONISHI, Shohei KAJIMOTO, Yusuke HAGIWARA, Yasuhiro MIHARA, Shogo NAKANO, Tomoharu MOTOYAMA, Sohei ITO